Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
  1. Home
  2. Search

Refine search

Refine search

Access:
Content type:
Publication date:
Apply   From and To filters
Subject: Show more
Journals Show more
Publishers: Show more
Societies Show more
Series: Show more
Collections: Show more

Actions for selected content:

Select all | Deselect all
  • View selected items
  • Export citations
  • Download PDF (zip)
  • Save to Kindle
  • Save to Dropbox
  • Save to Google Drive

Save Search

You can save your searches here and later view and run them again in "My saved searches".

Please provide a title, maximum of 40 characters.
Cancel
×

1 results

  • 9 - Co-occurring anxiety and depression: concepts, significance, and treatment implications

  • from Section 2 - Challenges in diagnosing pathological anxiety
  • Edited by Helen Blair Simpson, Columbia University, New York, Yuval Neria, Columbia University, New York, Roberto Lewis-Fernández, Columbia University, New York, Franklin Schneier, Columbia University, New York
  • Book:
    Anxiety Disorders
    Published online:
    10 November 2010
    Print publication:
    26 August 2010, pp 90-102

  • Summary

    This introductory chapter presents an overview of concepts covered in the following chapters of the book. It represents a selective review of the work undertaken over the last three decades to advance our understanding of anxiety and anxiety disorders. Research has transformed how we treat anxiety disorders: evidence-based practices have been developed and are being disseminated not only to mental health settings but also to primary care practices. Cognitive-behavioral approaches reign among psychotherapies, and the FDA has approved several classes of medication for the treatment of anxiety disorders. The focus has shifted away from identifying a treatment that can beat a placebo or usual care to developing better and novel treatments for those who do not fully respond to first-line treatments. Increasingly, these novel treatments are based on sophisticated theories of the mechanisms underlying the symptoms.